Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giulia Scalisi"'
Autor:
Kevin Petrecca, Alexandre Prat, John A. Heyman, Burkhard Becher, Jack P. Antel, Zhaorong Li, Michael A. Wheeler, Giulia Scalisi, Assaf Rotem, Charles P. Couturier, Liliana Maria Sanmarco, Iain C. Clark, Jeffrey R. Moffitt, Shravan Thaploo, Francisco J. Quintana, Stephanie Zandee, David A. Weitz, Veit Rothhammer, Jiannis Ragoussis, Sarah Alkwai, Brianna R. Watson, Emily C. Tjon
Publikováno v:
Nature, vol 578, iss 7796
Nature
Nature
Multiple sclerosis is a chronic inflammatory disease of the CNS(1). Astrocytes contribute to the pathogenesis of multiple sclerosis(2), but little is known about the heterogeneity of astrocytes and its regulation. Here we report the analysis of astro
Autor:
Alexandre Prat, Russ Hauser, Francisco J. Quintana, Manon Blain, Stephanie Zandee, Giulia Scalisi, Jessica E. Kenison, Merja Jaronen, Cristina Gutiérrez-Vázquez, Andreia Barroso, Michael A. Wheeler, Ruxandra Covacu, Jack P. Antel, Vijayaraghava T.S. Rao, Emily C. Tjon, Patrick Hewson, Veit Rothhammer, Chun-Cheih Chao
Publikováno v:
Cell. 176(3)
Genome-wide studies have identified genetic variants linked to neurologic diseases. Environmental factors also play important roles, but no methods are available for their comprehensive investigation. We developed an approach that combines genomic da
Autor:
Abdolmohamad Rostami, Carmine Vacca, Rita Romani, Marco Gargaro, James Crooks, Antonella Turco, Francesca Fallarino, Davide Matino, Bruno Gran, Paolo Puccetti, Matteo Pirro, Giulia Scalisi, Claudia Volpi
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Mediators of Inflammation
Mediators of Inflammation
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory, demyelinating disease of the CNS that mimics human multiple sclerosis (MS), and it is thought to be driven by Th1 and Th17 myelin-reactive cells. Although adaptive immunity is clearl
Autor:
Paolo Puccetti, Antonella Turco, Francesca Fallarino, Davide Matino, Marco Gargaro, Francisco J. Quintana, Alfonso Iorio, Giulia Scalisi
Publikováno v:
ResearcherID
Background: The development of inhibitors is the most serious complication a patient with hemophilia can experience on treatment with clotting factor concentrates. In a cohort of 100 severe hemophilia A patients, we have recently found that the inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8424464effe055406f936e066e4a5e
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000394452301004&KeyUID=WOS:000394452301004
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000394452301004&KeyUID=WOS:000394452301004